Company Overview
ACUMEN PHARMACEUTICALS, INC.
ABOSRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-121M
2025 FY
Shares Outstanding
61M
2025 FY
EPS
-2USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1576885
Exchange
Nasdaq
Location
US